Health Equity and Resilience: Aligning Investment for UHC, Innovation and Climate Action
Antimicrobial resistance (AMR) makes infections harder—and sometimes impossible—to treat, posing a serious threat to vulnerable populations lacking access to quality healthcare.
At the WHA78 side event “Health Equity and Resilience: Aligning Investment for UHC, Innovation and Climate Action,” organised by ISC Intelligence on May 21, 2025, our Deputy Director Ralf Sudbrak participated in a high-level panel alongside:
-
Ms. Eudy Mabuza, Senior Science and Innovation Representative, Embassy of South Africa in Brussels
-
Mr. Brian O’Connor, ECHAlliance – The Global Health Connector, UK
The discussion emphasized the vital role of science, research, and data in protecting vulnerable communities and guiding evidence-based investments in global health systems.
Key themes included:
-
Financing Universal Health Coverage (UHC)
-
Strengthening health systems and resilience
-
Reducing health inequalities
-
Supporting research and innovation through strategic investment
The event was part of a week of rich and inspiring dialogue during the 78th World Health Assembly.
💡 Read more about this side event
